Detalhe da pesquisa
1.
Targeting glutaminase is therapeutically effective in ibrutinib-resistant mantle cell lymphoma.
Haematologica
; 108(6): 1616-1627, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36420799
2.
Pirtobrutinib and venetoclax combination overcomes resistance to targeted and chimeric antigen receptor T-cell therapy in aggressive mantle cell lymphoma.
Haematologica
; 108(5): 1412-1416, 2023 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36475521
3.
The CDK9 inhibitor enitociclib overcomes resistance to BTK inhibition and CAR-T therapy in mantle cell lymphoma.
Biomark Res
; 12(1): 62, 2024 Jun 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38886769
4.
The HSP90-MYC-CDK9 network drives therapeutic resistance in mantle cell lymphoma.
Exp Hematol Oncol
; 13(1): 14, 2024 Feb 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38326887
5.
Potentiation of apoptosis in drug-resistant mantle cell lymphoma cells by MCL-1 inhibitor involves downregulation of inhibitor of apoptosis proteins.
Cell Death Dis
; 14(11): 714, 2023 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37919300
6.
Cotargeting of BTK and MALT1 overcomes resistance to BTK inhibitors in mantle cell lymphoma.
J Clin Invest
; 133(3)2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36719376
7.
Targeting FcγRIIB by antagonistic antibody BI-1206 improves the efficacy of rituximab-based therapies in aggressive mantle cell lymphoma.
J Hematol Oncol
; 15(1): 42, 2022 04 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35410313
8.
The antibody drug conjugate VLS-101 targeting ROR1 is effective in CAR T-resistant mantle cell lymphoma.
J Hematol Oncol
; 14(1): 132, 2021 08 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34454548
9.
Dual targeting of CDK4/6 and Bcl-2 exhibits a potent antitumor effect on mantle cell lymphoma.
Blood Adv
; 7(14): 3361-3365, 2023 07 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37257192